The 8th Cell & Gene Therapy Analytical Development Summit is a professional summit that examines analytical characterization, assay development, quality control, regulatory strategies, and manufacturing readiness for cell and gene therapy products, including AAV, lentiviral vectors, CAR-T therapies, and emerging genetic medicines.